Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
about
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.E-Cadherin repression increases amount of cancer stem cells in human A549 lung adenocarcinoma and stimulates tumor growth.Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.
P2860
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@ast
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@en
type
label
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@ast
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@en
prefLabel
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@ast
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@en
P2093
P2860
P356
P1433
P1476
Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma
@en
P2093
Hiroshi Kobayashi
Hitomi Sugimoto
Kazutoshi Nakano
Shunsuke Onishi
P2860
P304
P356
10.3892/OL.2015.3367
P577
2015-06-11T00:00:00Z